Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Reexamination Certificate
2005-03-22
2005-03-22
Myers, Carla J. (Department: 1634)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
C424S009100, C424S009341, C424S009600, C424S142100, C424S155100, C424S130100, C435S007100, C435S007210, C435S007230, C530S388100, C530S388150, C530S389100, C530S389700, C530S388800, C530S350000, C536S023500
Reexamination Certificate
active
06869592
ABSTRACT:
The present invention provides new methods for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating lung cancer.
REFERENCES:
patent: 5589579 (1996-12-01), Torczynski et al.
patent: 0 695 760 (1994-05-01), None
patent: WO 9820143 (1998-05-01), None
patent: WO 9820143 (1998-05-01), None
patent: WO 0008206 (2000-02-01), None
patent: WO 0078953 (2000-12-01), None
patent: WO 0122920 (2001-04-01), None
patent: WO 0164835 (2001-09-01), None
patent: WO 0210390 (2002-02-01), None
Kerlavage et al. National Center for Biotechnology Information, National Library of Medicine, NIH (Bethesda, MD, USA), GenBank Accession No. AA324584, Apr. 20, 1997.
Macina Roberto A.
Recipon Herve
Sun Yongming
Yang Fei
diaDexus, Inc.
Licata & Tyrrell P.C.
Myers Carla J.
LandOfFree
Method and antibody for imaging lung cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and antibody for imaging lung cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and antibody for imaging lung cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3451897